Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools

Author: Sawant Basak Aarti   Byon Wonkyung   Tseng-Lovering Elaine   Funk Carrie   Wood Linda   Lin Chang   Delnomdedieu Marielle   Verhoest Patrick   Parikh Vinod   Cox Loretta M.   Miller Emily   Gao Hongying   Obach Ronald S.  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.44, Iss.5, 2014-05, pp. : 438-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content